Dr. Ryutaro Hirose was recently appointed Chief of the Division of Transplant Surgery and Co - Director of the UW Medicine Transplant Institute, starting his position on November 1, 2023. Dr. Hirose is a senior and well-known transplant surgeon who had previously worked at UCSF. He has extensive experience in UNOS, within the American Society of Transplant Surgeons (ASTS) , and he currently serves as the Surgical Director of the Scientific Registry of Transplant Recipients (SRTR). As a leader in transplantation, Dr.

Hepatologist, responsible of the Hepatology and Liver Transplantation Unit at the Hospital Universitari i Politècnic La Fe, in Valencia, Spain.
Research Coordinator of the accredited group "Hepatology, Hepato-Biliary-Pancreatic Surgery, and Liver Transplantation" within the Biomedical Research Networking Center for Liver and Digestive Diseases (CIBEREHD) and La Fe Research Institute.
Professor of Medicine at the University of Valencia.
Full member of the Royal Academy of Medicine of the Valencian Community.
ILTS 2021-2022 past president.

Transplant Surgery, University of Pennsylvania

Nazia Selzner MD, PhD, MSc
Professor of Medicine
Director Center for Living Organ Donation
Medical Director Live Donor Liver Transplantation
Ajmera Transplant Center
University of Toronto, Toronto
President International Liver Transplantation Society (ILTS)

Dr. Manuel Mendizabal is the Chief of Hepatology at the Austral University Hospital in Buenos Aires. He received his medical degree from Austral University. He completed his training in Hepatology and Liver Transplantation at the University of Pennsylvania. He is part of the different regional scientific societies, being former Secretary and Internation Affairs of the Latin American Association for the Study of the Liver (ALEH). His areas of interest are viral hepatitis, acute liver failure, and liver transplantation having several publications in scientific journals and book chapters.

Dr. Rakhi Maiwall is currently working as a Professor of Hepatology and is the Head of the liver intensive care unit at the Institute of Liver and Biliary Sciences. She has a special interest in renal dysfunction in patients with cirrhosis and liver failure and critical care She is also the Vice-secretary of the international club of ascites and has published original articles in indexed journals and has more than 180 publications and contributed 12 book chapters.

Dr. Olson attended medical school at the University of Nebraska Medical Center in Omaha, Nebraska followed by residency at the University of Minnesota in the Centers for Disease Control Global Health Track. After residency he then completed advanced fellowships in Critical Care Medicine and Transplant Hepatology at Mayo Clinic in Rochester MN. Previously, he was an Associate Professor of Medicine and Surgery at the University of Kansas before returning to Mayo Clinic in 2023. Dr.

Catherine Williamson is Professor of Women's Health at Imperial College London. She is also Consultant in Obstetric Medicine at Queen Charlotte's, St Thomas' and King's College Hospitals. She is a Fellow of the Academy of Medical Sciences and is an Honorary Fellow of the RCOG. She is the Maternal Medicine Representative on the RCOG Genomics Committee and was Chair of the European and FIGO guideline committees for the guidelines on management of liver disorders in pregnancy.

Dr. Danielle Haakinson received her undergraduate degree in Biology at the University of Colorado in 1998, followed by working several years in biomedical research lab of Dr. E. Chester Ridgway studying diabetes and endocrinopathies. She graduated from University of Colorado School of Medicine in 2008 and then completed her residency training in general surgery as well as an abdominal transplant surgery fellowship at the Mayo Clinic in Scottsdale Arizona.

I am a Professor of Medicine in the Division of Gastroenterology and Hepatology and am certified in both gastroenterology and Hepatology and in Transplant Hepatology. My major clinical research focus is on the therapy and diagnosis of hepatocellular carcinoma (HCC). Our group at Northwestern University is very qualified for this particular study as our center is a major referral center for the management of HCC in all stages of disease.